Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...

Op dinsdag heeft Bernstein SocGen Group haar standpunt over Pfizer Inc. (NYSE: PFE) aandelen aangepast door het koersdoel te verlagen van $ 32,00 naar $ 30,00, terwijl het Market Perform-advies werd g ...

The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida ...

ADCETRIS, een antilichaam-geneesmiddelconjugaat, richt zich op CD30-positieve tumorcellen en is sinds de eerste goedkeuring ...

In a move that will raise eyebrows in Washington, Pfizer has hired the former director of the FDA's Center for Drug ...

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., ...

Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...